Combined with the observation that 53BP1 appeared to interact with p53 mutants in a manner that is mutant-specific, our results suggest that the yeast-based assay could be used to screen a large panel of tumor-associated p53 mutations for differential impact of these chemicals on p53 functional interaction with cofactors. The gene discussed is TP53; the disease is neoplasm.